💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Isis Pharmaceuticals, Inc. (ISIS)
« Back to company indexISIS Chatter Timeline
Stock Ticker for ISIS
Most Active Tweeters for ISIS
| User | Tweets |
|---|---|
| @Allstocknews | 2 |
Recent Tweets for ISIS
 |
@Allstocknews $ISIS Ionis announces AstraZeneca's initiation of the Phase 2b clinical study of its antisense medicine targe From our Stock News Alerts App November 30th 2020, 5:11pm |
|
@Allstocknews $ISIS Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) e From our Stock News Alerts App November 23rd 2020, 5:11pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Stifel 2020 Healthcare Conference From our Stock News Alerts App November 16th 2020, 12:11pm |
|
@Allstocknews $ISIS Promising new data for Ionis' antisense medicine targeting PCSK9 presented at American Heart Associatio From our Stock News Alerts App November 13th 2020, 7:11am |
|
@Allstocknews $ISIS Ionis' pioneering antisense technology to be featured in multiple presentations at American Heart Assoc From our Stock News Alerts App November 12th 2020, 7:11am |
|
@Allstocknews $ISIS Ionis' antisense technology to be featured during virtual RNA at the Bench and Bedside II Conference From our Stock News Alerts App November 10th 2020, 7:11am |
|
@Allstocknews $ISIS Ionis and Akcea Recognize FCS Awareness Day With Global Community Efforts to Celebrate Unsung Heroes From our Stock News Alerts App November 6th 2020, 3:11am |
 |
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Scientific Officer BENNETT C FRANK: Disposed 15,000 of Common Stock a… https://t.co/NkmKYlGXYK November 5th 2020, 8:11pm |
|
@Allstocknews $ISIS New Form 10-Q for Ionis Pharmaceuticals Inc From our Stock News Alerts App November 4th 2020, 6:11pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - RNA at the Bench and Bedside II Conference [Virtual] From our Stock News Alerts App November 4th 2020, 1:11pm |
|
@Allstocknews $ISIS New Form 8-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App November 4th 2020, 11:11am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on November 04, 11:15:46: Item2.02: Results of Operations & Financial Condition https://t.co/SfuXzGby7Y November 4th 2020, 11:11am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Third Quarter 2020 Earnings Webcast From our Stock News Alerts App November 4th 2020, 9:11am |
|
@Allstocknews $ISIS Ionis reports third quarter 2020 financial results and recent business achievements From our Stock News Alerts App November 4th 2020, 7:11am |
|
@Allstocknews $ISIS Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPT From our Stock News Alerts App November 3rd 2020, 6:11pm |
 |
@Astghine @realDonaldTrump Erdo?an said: "Europeans will not walk safely on the streets" https://t.co/dMIl4uOKsM $ISIS and Ev… https://t.co/F2yxTXq1xz November 3rd 2020, 4:11am |
 |
@15minofPham @Allen57531237 Dorsey should rename it $ISIS October 30th 2020, 12:10pm |
|
@Allstocknews $ISIS Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Produc From our Stock News Alerts App October 30th 2020, 7:10am |
 |
@Traderideas1 $ISIS level to watch https://t.co/rxUJMTPWsi October 27th 2020, 10:10am |
|
@Allstocknews $ISIS Ionis' third novel antisense medicine for ALS, its first designed to treat a broad ALS population, begi From our Stock News Alerts App October 22nd 2020, 7:10am |
 |
@WJP_Trades $ISIS top AH watch October 21st 2020, 3:10pm |
|
@Allstocknews $ISIS Ionis to hold third quarter 2020 financial results webcast From our Stock News Alerts App October 21st 2020, 7:10am |
|
@Allstocknews $ISIS Ionis antisense medicine being evaluated in an investigator-initiated clinical study of COVID-19 patien From our Stock News Alerts App October 15th 2020, 7:10am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: 10% Owner IONIS PHARMACEUTICALS INC: Acquired 21,237,715 of Common Stock at… https://t.co/c5SskG1kN9 October 14th 2020, 4:10pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC 13D/A on October 13, 08:47:58 https://t.co/hpei8PbPIh October 13th 2020, 8:10am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on October 13, 08:43:31: Item2.01: Completion of Acquisition or Disposition of… https://t.co/zU5joOZXng October 13th 2020, 8:10am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-T/A on October 13, 08:38:16 https://t.co/W0qtWEceZl October 13th 2020, 8:10am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-T/A on October 02, 17:29:20 https://t.co/a2wPEzc1rl October 2nd 2020, 5:10pm |
|
@Allstocknews $ISIS New Form SC 13G/A for Ionis Pharmaceuticals Inc From our Stock News Alerts App October 2nd 2020, 9:10am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC 13G/A on October 02, 09:38:22 https://t.co/ZcLymzoQqn October 2nd 2020, 9:10am |
|
@Allstocknews $ISIS Ionis Chief Scientific Officer Frank Bennett receives Lifetime Achievement Award from Oligonucleotide T From our Stock News Alerts App October 1st 2020, 4:10pm |
|
@Allstocknews $ISIS Ionis treatment for Alexander disease receives orphan drug designation from U.S. FDA From our Stock News Alerts App September 30th 2020, 5:09pm |
|
@Allstocknews $ISIS New Form SC TO-T/A for Ionis Pharmaceuticals Inc From our Stock News Alerts App September 24th 2020, 6:09pm |
 |
@biggermac2 RT @FlashAlert_me: $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Disposed 52,000 of Common Stock at… September 23rd 2020, 6:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Disposed 52,000 of Common Stoc… https://t.co/n4Q7sQaTBZ September 23rd 2020, 6:09pm |
 |
@PenthouseBurny @Stocktwits Funny story actually... $IONS... formally known as $ISIS... didn’t end well ?? September 23rd 2020, 11:09am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Bank of America Global Healthcare Conference From our Stock News Alerts App September 18th 2020, 7:09am |
 |
@HallowedCrow @AutisticAf Okay, sending five hunnid to $isis… September 17th 2020, 6:09pm |
|
@Allstocknews $ISIS New Form SC TO-T for Ionis Pharmaceuticals Inc From our Stock News Alerts App September 14th 2020, 5:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-T on September 14, 17:11:36 https://t.co/7z6OVIhBCu September 14th 2020, 5:09pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Morgan Stanley 18th Annual Global Healthcare Conference From our Stock News Alerts App September 14th 2020, 7:09am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Wells Fargo 2020 Healthcare Conference From our Stock News Alerts App September 10th 2020, 8:09am |
|
@Allstocknews $ISIS Ionis to present at upcoming virtual investor conferences From our Stock News Alerts App September 3rd 2020, 7:09am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Acquired 121 of Common Stock at pric… https://t.co/4UFKww4ylR September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP & General Counsel O'NEIL PATRICK R.: Acquired 169 of Common Stock at pr… https://t.co/nIRdrM0wCV September 2nd 2020, 7:09pm |
|
@Allstocknews $ISIS New Form 4 for Ionis Pharmaceuticals Inc From our Stock News Alerts App September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Development Geary Richard S: Acquired 1 of Common Stock at price $44.4… https://t.co/JSB1LQhza3 September 2nd 2020, 7:09pm |
|
@Allstocknews $ISIS New England Journal of Medicine publishes study results evaluating Ionis antisense therapy in treatment From our Stock News Alerts App September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Disposed 314 of Common Stock at pric… https://t.co/KY1DvGpka8 September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Scientific Officer BENNETT C FRANK: Acquired 112 of Common Stock at p… https://t.co/qAwAcWCBUV September 2nd 2020, 7:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
